HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell line

被引:23
作者
Tagliamonte, M. [1 ]
Visciano, M. L. [1 ]
Tornesello, M. L. [1 ]
De Stradis, A. [2 ]
Buonaguro, F. M. [1 ]
Buonaguro, L. [1 ,3 ]
机构
[1] Ist Nazl Tumori Fond G Pascale, Lab Mol Biol & Viral Oncogenesis, I-80131 Naples, Italy
[2] CNR, Inst Plant Virol, Bari, Italy
[3] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA
关键词
Virus-Like Particles; Delivery system; HIV; Stable expression; Insect cells; VIRUS-LIKE PARTICLES; HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN COMPLEX; HUMAN MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODIES; DENDRITIC CELLS; DISULFIDE BOND; T-CELL; PROTEINS; GP120;
D O I
10.1016/j.vaccine.2011.05.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously described the establishment and characterization of a stably transfected insect cell line for the constitutive and efficient expression of Pr55 HIV Gag proteins, which auto-assemble into enveloped Virus-Like Particles (VLPs) released into the cell culture supernatant. Such HIV-Gag VLPs have been shown to elicit a specific systemic humoral response in vivo, proving the appropriate antigenic presentation of the HIV Gag protein to the immune system. Here we describe the establishment of a stable double transfected insect cell line for the constitutive and reproducible production of Pr55Gag-VLPs expressing on their surface trimeric forms of HIV-1 envelope glycoproteins. The persistence of HIV coding genes has been verified in clonal resistant insect cells, the protein expression and conformation has been verified by Western blot analysis. The resulting HIV-VLPs have been visualized by standard transmission electron microscopy and their immunogenicity has been evaluated in vivo. This represents, to our knowledge, the first example of stable double transfected insect cell line for the constitutive production of enveloped HIV-Gag VLPs presenting trimeric HIV-gp140 on their surface. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4913 / 4922
页数:10
相关论文
共 66 条
[1]   Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8(+) cytotoxic T lymphocytes [J].
Bachmann, MF ;
Lutz, MB ;
Layton, GT ;
Harris, SJ ;
Fehr, T ;
Rescigno, M ;
RicciardiCastagnoli, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (11) :2595-2600
[2]   Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[3]   A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure [J].
Binley, JM ;
Sanders, RW ;
Clas, B ;
Schuelke, N ;
Master, A ;
Guo, Y ;
Kajumo, F ;
Anselma, DJ ;
Maddon, PJ ;
Olson, WC ;
Moore, JP .
JOURNAL OF VIROLOGY, 2000, 74 (02) :627-643
[4]   EUKARYOTIC VIRUS DISPLAY - ENGINEERING THE MAJOR SURFACE GLYCOPROTEIN OF THE AUTOGRAPHA-CALIFORNICA NUCLEAR POLYHEDROSIS-VIRUS (ACNPV) FOR THE PRESENTATION OF FOREIGN PROTEINS ON THE VIRUS SURFACE [J].
BOUBLIK, Y ;
DIBONITO, P ;
JONES, IM .
BIO-TECHNOLOGY, 1995, 13 (10) :1079-1084
[5]   GENERATION OF HUMAN MONOCLONAL-ANTIBODIES AGAINST HIV-1 PROTEINS - ELECTROFUSION AND EPSTEIN-BARR-VIRUS TRANSFORMATION FOR PERIPHERAL-BLOOD LYMPHOCYTE IMMORTALIZATION [J].
BUCHACHER, A ;
PREDL, R ;
STRUTZENBERGER, K ;
STEINFELLNER, W ;
TRKOLA, A ;
PURTSCHER, M ;
GRUBER, G ;
TAUER, C ;
STEINDL, F ;
JUNGBAUER, A ;
KATINGER, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) :359-369
[6]  
Buonaguro FM, 2009, EXPERT REV VACCINES, V8, P1379, DOI [10.1586/erv.09.81, 10.1586/ERV.09.81]
[7]   DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity [J].
Buonaguro, L. ;
Devito, C. ;
Tornesello, M. L. ;
Schroder, U. ;
Wahren, B. ;
Hinkula, J. ;
Buonaguro, F. M. .
VACCINE, 2007, 25 (32) :5968-5977
[8]   Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation [J].
Buonaguro, L ;
Visciano, ML ;
Tornesello, ML ;
Tagliamonte, M ;
Biryahwaho, B ;
Buonaguro, FM .
JOURNAL OF VIROLOGY, 2005, 79 (11) :7059-7067
[9]   HETERODUPLEX MOBILITY ASSAY AND PHYLOGENETIC ANALYSIS OF V3 REGION SEQUENCES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES FROM GULU, NORTHERN UGANDA [J].
BUONAGURO, L ;
DELGAUDIO, E ;
MONACO, M ;
GRECO, D ;
CORTI, P ;
BETHGIRALDO, E ;
BUONAGURO, FM ;
GIRALDO, G ;
TAMBURINI, M ;
CASTELLO, G ;
DECLICH, S ;
LUKWIYA, M ;
SEMPALA, S ;
BIRYAMWAHO, B ;
DOWNING, R .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7971-7981
[10]   Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A [J].
Buonaguro, L ;
Racioppi, L ;
Tornesello, ML ;
Arra, C ;
Visciano, ML ;
Biryahwaho, B ;
Sempala, SDK ;
Giraldo, G ;
Buonaguro, FM .
ANTIVIRAL RESEARCH, 2002, 54 (03) :189-201